|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Yeo W, Mok TS, Zee B, Leung TW, Lai PB,
Lau WY, Koh J, Mo FK, Yu SC, Chan AT, et al: A randomized phase III
study of doxorubicin versus cisplatin/interferon
alpha-2b/doxorubicin/fluorouracil (PIAF) combination chemotherapy
for unresectable hepatocellular carcinoma. J Natl Cancer Inst.
97:1532–1538. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Gish RG, Porta C, Lazar L, Ruff P, Feld R,
Croitoru A, Feun L, Jeziorski K, Leighton J, Gallo J and Kennealey
GT: Phase III randomized controlled trial comparing the survival of
patients with unresectable hepatocellular carcinoma treated with
nolatrexed or doxorubicin. J Clin Oncol. 25:3069–3075. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wang XQ, Ongkeko WM, Chen L, Yang ZF, Lu
P, Chen KK, Lopez JP, Poon RT and Fan ST: Octamer 4 (Oct4) mediates
chemotherapeutic drug resistance in liver cancer cells through a
potential Oct4-AKT-ATP-binding cassette G2 pathway. Hepatology.
52:528–539. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chua CW and Choo SP: Targeted therapy in
hepatocellular carcinoma. Int J Hepatol. 2011:3482972011.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Dai ZJ, Tang W, Lu WF, Gao J, Kang HF, Ma
XB, Min WL, Wang XJ and Wu WY: Antiproliferative and apoptotic
effects of β-elemene on human hepatoma HepG2 cells. Cancer Cell
Int. 13:272013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Esteller M: Epigenetic gene silencing in
cancer: The DNA hypermethylome. Hum Mol Genet 16 Spec No.
1:R50–R59. 2007. View Article : Google Scholar
|
|
8
|
Holliday R and Pugh JE: DNA modification
mechanisms and gene activity during development. Science.
187:226–232. 1975. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Feng S, Jacobsen SE and Reik W: Epigenetic
reprogramming in plant and animal development. Science.
330:622–627. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bonasio R, Tu S and Reinberg D: Molecular
signals of epigenetic states. Science. 330:612–616. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Feinberg AP and Tycko B: The history of
cancer epigenetics. Nat Rev Cancer. 4:143–153. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Herman JG and Baylin SB: Gene silencing in
cancer in association with promoter hypermethylation. N Engl J Med.
349:2042–2054. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sharma S, Kelly TK and Jones PA:
Epigenetics in cancer. Carcinogenesis. 31:27–36. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Taby R and Issa JP: Cancer epigenetics. CA
Cancer J Clin. 60:376–392. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kondo Y: Epigenetic cross-talk between DNA
methylation and histone modifications in human cancers. Yonsei Med
J. 50:455–463. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ghoshal K and Bai S: DNA
methyltransferases as targets for cancer therapy. Drugs Today
(Barc). 43:395–422. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Oki Y, Aoki E and Issa JP:
Decitabine-bedside to bench. Crit Rev Oncol Hematol. 61:140–152.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Gorbunova V, Seluanov A, Mittelman D and
Wilson JH: Genome-wide demethylation destabilizes CTG.CAG
trinucleotide repeats in mammalian cells. Hum Mol Genet.
13:2979–2989. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Mund C, Hackanson B, Stresemann C, Lübbert
M and Lyko F: Characterization of DNA demethylation effects induced
by 5-Aza-2′-deoxycytidine in patients with myelodysplastic
syndrome. Cancer Res. 65:7086–7090. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yoo CB, Jeong S, Egger G, Liang G,
Phiasivongsa P, Tang C, Redkar S and Jones PA: Delivery of
5-aza-2′-deoxycytidine to cells using oligodeoxynucleotides. Cancer
Res. 67:6400–6408. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Datta J, Ghoshal K, Denny WA, Gamage SA,
Brooke DG, Phiasivongsa P, Redkar S and Jacob ST: A new class of
quinoline-based DNA hypomethylating agents reactivates tumor
suppressor genes by blocking DNA methyltransferase 1 activity and
inducing its degradation. Cancer Res. 69:4277–4285. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Gros C, Fleury L, Nahoum V, Faux C,
Valente S, Labella D, Cantagrel F, Rilova E, Bouhlel MA,
David-Cordonnier MH, et al: New insights on the mechanism of
quinoline-based DNA Methyltransferase inhibitors. J Biol Chem.
290:6293–6302. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Palii SS and Robertson KD: Epigenetic
control of tumor suppression. Crit Rev Eukaryot Gene Expr.
17:295–316. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kulis M and Esteller M: DNA methylation
and cancer. Adv Genet. 70:27–56. 2010.PubMed/NCBI
|
|
25
|
Garcia-Dominguez P, Dell'aversana C,
Alvarez R, Altucci L and de Lera AR: Synthetic approaches to DNMT
inhibitor SGI-1027 and effects on the U937 leukemia cell line.
Bioorg Med Chem Lett. 23:1631–1635. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ronen M, Avrahami D and Gerber D: A
sensitive microfluidic platform for a high throughput DNA
methylation assay. Lab Chip. 14:2354–2362. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Elmore S: Apoptosis: A review of
programmed cell death. Toxicol Pathol. 35:495–516. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Renault TT, Teijido O, Antonsson B, Dejean
LM and Manon S: Regulation of Bax mitochondrial localization by
Bcl-2 and Bcl-x(L): Keep your friends close but your enemies
closer. Int J Biochem Cell Biol. 45:64–67. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Hata AN, Engelman JA and Faber AC: The
BCL2 family: Key mediators of the apoptotic response to targeted
anticancer therapeutics. Cancer Discov. 5:475–487. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Siddiqui WA, Ahad A and Ahsan H: The
mystery of BCL2 family: Bcl-2 proteins and apoptosis: An update.
Arch Toxicol. 89:289–317. 2015. View Article : Google Scholar : PubMed/NCBI
|
